title: [Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
abstract: According to the principles of evidence-based medicine, the controlled studies on the treatment of idiopathic headache in childhood have been analysed and compiled to treatment recommendations. For the acute treatment of migraine attacks or tension-type headache, ibuprofen (10 mg per kg body weight) or acetaminophen (15 mg per kg body weight) are recommended with highest evidence, intranasal sumatriptan (10 to 20 mg) can be given as second choice. For the prophylaxis of migraine, betablockers (propranolol and metoprolol), flunarizine, and valproic acid are recommended. Flunarizine is the drug of first choice in the treatment of migraine-related disorders. No controlled studies are available for the treatment of further headache types. First line methods for the non-drug treatment of headache in childhood are relaxation therapies, biofeedback, and specific training schedules.
authors.affiliation: Klinik und Poliklinik für Neurologie, Westfälische Wilhelms-Universität Münster, Germany. everss@uni-muenster.de
authors.forename: S
authors.initials: S
authors.lastname: Evers
authors.forename: R
authors.initials: R
authors.lastname: Pothmann
authors.forename: M
authors.initials: M
authors.lastname: Uberall
authors.forename: E
authors.initials: E
authors.lastname: Naumann
authors.forename: W D
authors.initials: WD
authors.lastname: Gerber
mesh_terms: D000082:Acetaminophen / Q000008:administration & dosage / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000367:Age Factors; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002648:Child; D005444:Flunarizine / Q000008:administration & dosage / Q000627:therapeutic use; D018682:GABA Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage / Q000627:therapeutic use; D008790:Metoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D012064:Relaxation Therapy; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D018170:Sumatriptan / Q000008:administration & dosage / Q000627:therapeutic use; D018781:Tension-Type Headache / Q000188:drug therapy; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D018712:Analgesics, Non-Narcotic; D018682:GABA Agents; D017366:Serotonin Receptor Agonists; D014665:Vasodilator Agents; D000082:Acetaminophen; D014635:Valproic Acid; D018170:Sumatriptan; D011433:Propranolol; D008790:Metoprolol; D005444:Flunarizine; D007052:Ibuprofen